Invesaro

Stocks SGI Financial statements

Financial statements

SOMNIGROUP INTERNATIONAL INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SOMNIGROUP INTERNATIONAL INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,1292,7542,7033,1063,6774,9314,9214,9254,9317,477
Cost of revenue1,7901,5801,5821,7642,0392,7722,8722,9392,9034,293
Gross profit1,2901,1211,1211,3421,6382,1592,0501,9862,0283,183
Research and development26.721.721.92323.127.329.230.630.832.9
Selling and marketing6365865886667409239939219391,739
Operating income413296256347532912681607634755
Interest expense82.987.392.385.77766.3103130135268
Other non-operating income-130-80.1-91.3-81.2-79.7-88.3-103-133-130-274
Pre-tax income284215165266452824577474504481
Income tax86.343.849.674.710319811910311995.7
Income from continuing operations625456368384384
Net income to minority interests-5.6-10.7-2.9-0.110.52.12.61.4
Net income191151101190349625456368384384
EBITDA5023903684637351,0878617908361,045
EPS, basic0.820.710.460.871.683.172.612.142.211.86
EPS, diluted0.810.700.460.861.643.062.532.082.161.84
Shares, basic (weighted)233214218218208197175172174206
Shares, diluted (weighted)237216220222212204180177178209
Dividend per share0.320.400.440.520.60

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents64.641.145.864.96530169.474.91,710135
Receivables342311322372384420423431405359
Inventory197179222261312464555483447630
Other current assets63.963.421620320891.514811496.5171
Total current assets6686078059009681,2761,1951,1031,0651,294
Property, plant and equipment4224344214365085847918788111,019
Lease right-of-use assets02453044815076375991,879
Goodwill6997337237327661,1071,0621,0831,0674,596
Intangible assets6796676496416307517167157012,587
Other non-current assets18522794.392.611811277.3122130207
Total assets2,6992,6942,7153,0623,3094,3234,3604,5545,98011,601
Accounts payable235228253252324432360311361402
Accrued liabilities250222359473585457433427394637
Deferred revenue51.548.553.359.3105
Short-term debt70.372.447.137.443.95370.444.969.5112
Total current liabilities5615776697739751,0539819089601,565
Long-term debt1,8181,6811,5991,5031,3232,2792,7402,5273,7404,573
Lease liabilities02052754274545755321,590
Other non-current liabilities18020611211813214083.582.671131
Total liabilities2,7332,5792,4982,7012,7954,0284,3724,2215,4128,484
Total debt1,8881,7531,6461,5401,2992,2782,7522,5023,7564,607
Paid-in capital4935085325746186225985595011,039
Retained earnings1,2651,4161,5141,7032,0462,6052,9893,2793,5723,829
Treasury stock-1,700-1,737-1,737-1,833-2,097-2,845-3,435-3,381-3,330-1,664
Other comprehensive income-104-75.5-95.3-87.7-65.5-99.2-177-137-187-98.4
Shareholders' equity-44.9113215360504286
Minority interests302.90.910
Total equity-41.9113218360505286-22.13235593,108
Total liabilities and equity2,6992,6942,7153,0623,3094,3234,3604,5545,98011,601

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income18514197.6189350625458371386385
Depreciation and amortization88.694112117203175180183202291
Stock-based compensation16.213.324.826.810561.453.147.736.441
Deferred income tax-31.1-61.16-7.1-8.611.1-10.58.3-19.225.8
Change in receivables21.521-46.3-76-55.7-40.4-14.8-11.5-7.372.6
Change in inventory0.716.3-44.6-28.2-42.5-106-10275.826.8137
Change in payables-48.33.828.7-4.86350.5-59.5-46.958.3-133
Cash from operations166223208315655723379570667800
Capital expenditures-61.9-66.6-73.6-88.2-111-123-307-185-97.3-167
Acquisitions000-17.1-41.2-4330-30-2,825
Purchases of investments00-41.7
Cash from investing-62.4-62.1-71.2-90.2-147-555-315-188-96.7-3,024
Stock issued15.712.84.617.86.914.90.52.90.549.5
Share buybacks-535-44.9-4.6-106-332-816-667-36-43.8-132
Dividends paid00-63.1-70.5-77.7-92.7-127
Cash from financing-185-175-107-203-52376.5-279-3841,077617
Exchange rate effect-6.2-9.4-3.1-0.3
Net change in cash-88.2-23.83.919.10.1236-2315.51,635-1,575
Free cash flow10415613422754360072.3385569633
Interest paid75.486.691.8897955.2106145158278
Income taxes paid81.379.832.573.893.818513813313441.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $63.95 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin44.2%Gross profit / revenue.
Operating margin12.5%Operating income / revenue.
EBITDA margin16.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin9.4%Pre-tax income / revenue.
Net margin7.0%Net income / revenue.
FCF margin10.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin13.0%Cash from operations / revenue.
Effective tax rate25.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)4.6%Net income / average total assets.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.9%Capital expenditures / revenue.
D&A / revenue4.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y51.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y15.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y15.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y57.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y15.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y14.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y19.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y3.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y25.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y6.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y7.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-0.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-5.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y1.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-14.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-10.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y2.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y20.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y28.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y4.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y11.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y106.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y3.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y15.4%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y14.5%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y94.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y38.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y28.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y17.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y5.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.75xCurrent assets / current liabilities.
Quick ratio0.27x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.07x(Cash + short-term investments) / current liabilities.
Debt / assets38.0%Total debt / total assets.
Liabilities / assets72.1%Total liabilities / total assets.
Net debt$4.30BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.43xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.76xOperating income / interest expense.
Working capital-$434.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets61.7%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.66xRevenue / average total assets.
Fixed asset turnover7.54xRevenue / average property, plant and equipment.
Inventory turnover6.53xCost of revenue / average inventory.
Days inventory56 days365 x average inventory / cost of revenue.
Receivables turnover21.1xRevenue / average receivables.
Days sales outstanding17 days365 x average receivables / revenue.
Days payables45 days365 x average accounts payable / cost of revenue.
Cash conversion cycle28 daysDays inventory + days sales outstanding - days payables.
FCF conversion144.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow22.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.51Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$35.84Revenue / diluted weighted shares.
FCF per share$3.62Free cash flow / diluted weighted shares.
Operating cash flow per share$4.66Cash from operations / diluted weighted shares.
Cash per share$0.53(Cash + short-term investments) / shares outstanding.
Payout ratio25.4%Dividends paid / net income, when net income is positive.
Dividends / FCF17.6%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF3.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$13.45BShare price x shares outstanding.
Enterprise value$17.75BMarket cap + total debt - cash - short-term investments.
P/E25.2xMarket cap / net income. Only when net income is positive.
P/S1.77xMarket cap / revenue.
P/FCF17.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF13.6xMarket cap / cash from operations, when positive.
EV/Sales2.33xEnterprise value / revenue.
EV/EBIT18.7xEnterprise value / operating income, when both are positive.
EV/EBITDA14.2xEnterprise value / EBITDA, when both are positive.
EV/FCF23.1xEnterprise value / free cash flow, when both are positive.
FCF yield5.7%Free cash flow / market cap.
Earnings yield4.0%Net income / market cap (the inverse of P/E).
Dividend yield1.0%Dividends paid over the period / market cap.
Shareholder yield1.2%(Dividends paid + share buybacks) / market cap.
What was SOMNIGROUP INTERNATIONAL INC.'s revenue in fiscal 2025?

SOMNIGROUP INTERNATIONAL INC. reported revenue of $7.48B for fiscal 2025, 51.6% higher than the year before.

Was SOMNIGROUP INTERNATIONAL INC. profitable in fiscal 2025?

Yes. Net income was $384.1M, a net margin of 5.1%.

How much free cash flow did SOMNIGROUP INTERNATIONAL INC. generate in fiscal 2025?

Cash from operations of $800.1M minus capital expenditures of $166.9M left free cash flow of $633.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SOMNIGROUP INTERNATIONAL INC.